Schedule 13D ownership disclosure
CHINOOK THERAPEUTICS INC
Security class unavailable · CUSIP: 16961L106
Event date: 2022-01-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-22-008701
- Form type
- SC 13D
- Filer
- CHINOOK THERAPEUTICS, INC.
- CIK
- CIK 1435049
- Filed
- Jan 13, 2022
- Reporting period
- Jan 03, 2022
- Description
- Schedule 13D beneficial ownership